Abstract
This pilot randomized controlled trial (RCT) aimed to determine whether an 8-week progressive step exercise program improves sarcopenic outcomes compared with treadmill exercise and a nonexercise control condition in women with sarcopenia. The primary outcomes were appendicular skeletal muscle mass (ASM), grip strength, calf circumference, and five-times sit-to-stand (5×STS) performance. As secondary objectives, we examined the effects of the intervention on body composition, cardiorespiratory fitness, and skeletal muscle oxygen saturation (SmO2). Thirty-six women were randomly assigned, but 30 were included in the analysis across three groups: a control group (CON, n=10), a treadmill exercise group (TEG, n=10), and a step exercise group (SEG, n=10). Compared with the CON and TEG, the SEG demonstrated significant between-group differences in calf circumference (P=0.001, η2= 0.422), grip strength (P=0.003, η2=0.393), 5×STS (P<0.001, η2=0.617), and ASM (P=0.046, η2=0.194). Significant between-group differences were observed for postintervention maximal oxygen uptake (P<0.001, η2=0.571) and maximal heart rate (P=0.018, η2=0.193). During graded exercise, significant between-group differences in SmO2 emerged from level 4 (P<0.05) and persisted through level 10 (P<0.01). These preliminary findings suggest that step exercise may be a promising and practical intervention for improving sarcopenic outcomes, aerobic capacity, and muscle oxidative adaptation in women with sarcopenia. However, larger adequately powered RCTs are required to confirm these findings and establish the efficacy of this intervention.
Keywords: Sarcopenia, Female, Step exercise, Aerobic exercise, Muscle oxygen saturation
INTRODUCTION
Sarcopenia is a progressive, age-related skeletal muscle disorder characterized by declines in muscle mass, muscle strength, and physical performance, representing a major public health concern in rapidly aging populations (Cruz-Jentoft et al., 2019). Its prevalence increases markedly with age, particularly among postmenopausal women, owing to hormonal alterations and reduced levels of physical activity (Kim and Choi, 2013). The condition is closely associated with frailty, falls, functional disability, diminished quality of life, and increased healthcare costs, thereby imposing a substantial socioeconomic burden worldwide (Beaudart et al., 2017; Landi et al., 2013). According to the Asian Working Group for Sarcopenia (AWGS), reduced muscle strength is the primary indicator of sarcopenia, while low muscle mass and impaired physical performance are essential criteria for diagnosis and grading of disease severity (Chen et al., 2020; Cruz-Jentoft et al., 2019).
Exercise intervention is widely recognized as the cornerstone of sarcopenia management because it is both effective and readily accessible. A growing body of evidence indicates that aerobic exercise plays a pivotal role in preserving functional independence and physical capacity throughout the aging process. Maximal oxygen uptake (VO2max), the gold-standard measure of cardiorespiratory fitness, is strongly associated with mobility, cardiovascular function, and mortality (Kodama et al., 2009). Improvements in VO2max have consistently been linked to enhanced exercise capacity and functional performance, whereas reduced aerobic fitness is closely associated with the development and progression of sarcopenia (Moghadam et al., 2020). In addition, resistance training and multicomponent exercise programs that integrate aerobic and resistance exercises are recommended because they produce superior improvements in muscle strength, physical function, and overall fitness (Fragala et al., 2019). Despite these well-established benefits, many conventional exercise interventions require specialized equipment, supervised settings, or sustained adherence, which may limit their feasibility and long-term implementation.
Step exercise has recently emerged as a practical, low-cost, and highly accessible form of weight-bearing exercise that integrates both aerobic and resistance-training characteristics. These repeated stimuli may promote skeletal muscle adaptation and contribute to increases in muscle mass and functional capacity. Simultaneously, the greater metabolic demand of stepping increases cardiovascular and oxygen requirements, which may stimulate improvements in cardiorespiratory fitness and peripheral muscle oxidative capacity (Jenkins et al., 2019; Van Roie et al., 2025). Compared with level walking, repeated stepping requires individuals to elevate their body mass against gravity, resulting in greater activation of the lower-extremity musculature and increased metabolic demand (Teh and Aziz, 2002). Furthermore, the repetitive concentric and eccentric muscle contractions involved in stepping provide a stronger mechanical loading stimulus than conventional walking, thereby promoting neuromuscular adaptation and muscle function (Lay et al., 2006). Previous studies have demonstrated that step-based exercise can effectively improve lower-limb muscle strength, balance, gait performance, and cardiorespiratory fitness across adult female populations (Boreham et al., 2000; Teh and Aziz, 2002). Previous randomized trials have also shown that progressive bench- or stair-stepping exercise can improve lower-extremity muscle volume, strength, power, functional performance, and cardiorespiratory fitness (Baggen et al., 2019; Jenkins et al., 2019; Van Roie et al., 2025). Moreover, review-level evidence indicates that stair-climbing interventions may improve aerobic capacity and several cardiometabolic risk factors, supporting their potential as an accessible exercise strategy (Ghosal and Chandrasekaran, 2023). Despite growing interest in step-based exercise, however, its physiological adaptations in women with sarcopenia remain insufficiently characterized. In particular, the mechanisms by which step exercise enhances peripheral skeletal muscle efficiency have yet to be fully elucidated.
Skeletal muscle oxygen saturation (SmO2), assessed using near-infrared spectroscopy (NIRS), provides noninvasive, real-time information on the balance between oxygen delivery and utilization within active skeletal muscle (Perrey and Ferrari, 2018) and may therefore offer additional insight into peripheral adaptations beyond conventional cardiorespiratory measures. However, SmO2 has rarely been incorporated into exercise intervention studies involving women with sarcopenia, and direct comparisons of peripheral oxygenation responses between step exercise and treadmill walking remain limited. In other words, the changes in SmO2 offer unique insights into local muscle oxidative metabolism, oxygen extraction, and microvascular adaptations, thereby complementing conventional cardiopulmonary measures that primarily reflect systemic physiological responses (Jones et al., 2019). Exercise-induced improvements in SmO2 have been linked to enhanced mitochondrial function, greater capillary density, and improved skeletal muscle oxidative capacity, thereby contributing to superior functional performance (Grassi et al., 2015). Nevertheless, NIRS-derived SmO2 has rarely been incorporated into intervention studies involving women with sarcopenia. Furthermore, while aerobic exercise, resistance training, and step exercise have each demonstrated beneficial effects, their integrated impact on sarcopenic outcomes, cardiorespiratory fitness, and peripheral muscle oxygenation has not been adequately investigated. Treadmill walking is a widely used form of aerobic exercise, whereas step exercise imposes greater weight-bearing and mechanical loading on the lower extremities, making treadmill walking an appropriate comparison intervention. Comparing these two exercise modalities may help determine whether the additional mechanical stimulus provided by step exercise offers greater benefits for sarcopenia-related outcomes, cardiorespiratory fitness, and muscle oxygenation.
Therefore, this pilot study was conducted to explore and compare the effects of an 8-week progressive step exercise program and treadmill walking on sarcopenia-related physiological indicators, cardiorespiratory fitness, and SmO2 in women with sarcopenia. We hypothesized that, compared with treadmill exercise and the control condition, step exercise would produce greater improvements in the primary outcomes of appendicular skeletal muscle mass (ASM), grip strength, calf circumference, and five-times sit-to-stand (5×STS) performance. As secondary hypotheses, we expected step exercise to result in greater improvements in body composition, cardiorespiratory fitness, and peripheral muscle oxygenation.
MATERIALS AND METHODS
Participants
Participants were women aged 41–58 years who were recruited from local communities in Seosan, Republic of Korea, between March 3 and 20, 2026. Eligibility criteria included: (1) no medical contraindications to exercise within the previous 3 months; (2) clearance to perform moderate-to-vigorous aerobic exercise based on pre-exercise health screening in accordance with the American College of Sports Medicine guidelines (Thompson et al., 2013); (3) a diagnosis of sarcopenia or classification as being at risk of sarcopenia according to the diagnostic criteria of the AWGS (Chen et al., 2020; Cruz-Jentoft et al., 2019); (4) no participation in structured exercise programs (≥3 sessions/wk, ≥30 min/session) during the previous 3 months; and (5) willingness and ability to complete the intervention and all outcome assessments. Participants were excluded if they had: (1) experienced major cardiovascular or cerebrovascular events within the previous 6 months or exhibited high-risk symptoms during exercise testing, such as chest pain or syncope; (2) uncontrolled hypertension, clinically significant arrhythmias, or other severe cardiovascular diseases that could contraindicate exercise participation; (3) severe musculoskeletal disorders limiting participation in step or treadmill exercise, including recent fractures or surgery, severe osteoarthritis, or disabling low back or lower-extremity pain; (4) neurological disorders associated with marked impairments in balance or gait; (5) severe respiratory diseases that restricted exercise performance; (6) medical conditions or medications known to substantially affect skeletal muscle mass or metabolism, including long-term systemic corticosteroid use, active cancer treatment, or uncontrolled thyroid disease; (7) substantial unintended weight change during the previous 3 months; or (8) any other condition that, in the investigators’ judgment, could compromise participant safety or adherence to the study protocol (Thompson et al., 2013).
As this was a pilot study, a formal sample size calculation based on statistical power was not performed. Instead, the sample size was determined pragmatically to evaluate the feasibility of the intervention, obtain preliminary estimates of treatment effects, and inform the design and sample size calculation of a future adequately powered randomized controlled trial (Eldridge et al., 2016).
Experimental design
This pilot study was conducted as an 8-week, single-center, single-blind, randomized controlled trial with a three-arm parallel-group design to evaluate the effects of step exercise on sarcopenia-related outcomes, cardiorespiratory fitness, and SmO2 in women with sarcopenia. To preserve blinding, outcome assessors and exercise instructors performed separate roles. Assessors remained unaware of group allocation throughout the study and completed all baseline and postintervention measurements, whereas exercise instructors were responsible solely for delivering the interventions. Blinding was maintained until completion of all outcome assessments and data collection, and group assignments remained confidential throughout the trial. Randomization was conducted by an independent investigator who was not involved in participant recruitment, intervention delivery, or outcome assessment using the Research Randomizer program. Each participant selected a numbered ticket from a container, and the corresponding number was entered into the randomization program.
An independent investigator who was not involved in participant recruitment, intervention delivery, or outcome assessment generated the allocation sequence using the Research Randomizer program. Participants were assigned in a 1:1:1 ratio to the control group (CON), treadmill exercise group (TEG), or step exercise group (SEG) as shown in Fig. 1. Group assignments were concealed from the investigators responsible for recruitment and baseline assessment until participant enrollment and baseline measurements had been completed. The allocation information was then released by the independent investigator to the exercise instructor responsible for implementing the assigned intervention.
Fig. 1.

CONSORT (Consolidated Standards of Reporting Trials) flow diagram.
As illustrated in Fig. 1, 40 women were initially recruited for this pilot study. Of these, four were excluded because they did not meet the eligibility criteria. The remaining 36 participants completed the baseline assessments and were randomly allocated to the CON, TEG, or SEG. During the 8-week intervention, two participants from each group withdrew, resulting in a final sample of 30 participants (10 per group) for the analysis. The study was conducted in accordance with the principles of the Declaration of Helsinki (World Medical Association, 2013) and was approved by the institutional review board of Hanseo University (approval No. HS26-0515-07). Written informed consent was obtained from all participants prior to enrollment.
Intervention program
Baseline assessments were conducted between March 9 and March 13, 2026. Beginning on March 16, 2026, participants in the TEG and SEG performed their respective exercise interventions until May 8, 2026. Follow-up assessments were subsequently carried out between May 11 and 15, 2026. Participants in the CON were instructed to maintain their usual activities of daily living throughout the study period and received guidance to perform 30 min of light stretching each day. However, they were asked to refrain from participating in any structured or planned exercise program during the intervention period. Both exercise groups performed a supervised aerobic program 5 times per week for 8 weeks. Each exercise session lasted 30 min. Exercise intensity was initially set at 60% of the heart rate reserve (HRR) and progressively increased by 10% every 3 weeks, reaching 80% HRR during the final phase of the intervention. Prior to each exercise session, participants completed a standardized 10-min warm-up under the supervision of a trained researcher. The TEG performed the exercise sessions in the morning, whereas the SEG trained in the afternoon. The SEG performed step exercise using a 15-cm-high step platform at a cadence of approximately 80–100 steps/min. To ensure consistency among participants, the stepping cadence was standardized using a metronome. Each exercise session consisted of three 10-min sets, with a 3-min rest interval between sets. Exercise intensity was adjusted to maintain the same target HRR and rate of perceived exertion (RPE) levels as those prescribed for the TEG. Participants were instructed to maintain an RPE between 3 and 6 on the Borg CR10 scale throughout each session (Borg, 1982).
Before measuring SmO2, the skinfold thickness of the vastus lateralis at the sensor attachment site was measured using a plastic analog skinfold caliper (Zhong Yan Co., China). During the 30-min intervention session, the SmO2 and total hemoglobin were assessed using a Moxy Monitor (Fortiori Design LLC, USA), a continuous-wave NIRS device equipped with one light emitter and two detectors positioned from the emitter (Lahade et al., 2026). Data were acquired continuously at an output frequency of 0.5 Hz throughout the assessment. SmO2 was monitored during three phases: rest, exercise, and recovery. SmO2 during the rest and recovery phases was recorded while participants remained seated for 3 min. Exercise SmO2 was monitored continuously throughout the 30-min exercise session and analyzed in 10 consecutive 3-min stages, with the first 3 min designated as Stage 1. Following each exercise session, participants completed a 10-min cool-down under the supervision of trained exercise specialists. Throughout the intervention, participants were monitored for adverse events, including dizziness, chest pain, dyspnea, and musculoskeletal discomfort. No serious adverse events occurred during the study.
Outcome measures
The primary outcomes were sarcopenia-related measures, including ASM, grip strength, calf circumference, and the 5×STS test. Secondary outcomes included body composition, cardiorespiratory fitness, and vastus lateralis SmO2. All outcome measures were assessed at baseline and after the 8-week intervention. Participants were instructed to refrain from vigorous physical activity for 48 hr, alcohol and caffeine consumption for 24 hr, and food intake for at least 8 hr before each assessment. To minimize the effects of circadian variation, all measurements were performed at the same time of day under standardized laboratory conditions, with the ambient temperature maintained at 22–24°C and relative humidity at 45%–55%.
Demographic and daily life characteristics
Demographic characteristics included age, educational attainment, marital status, living arrangement, self-rated health status, physician-diagnosed chronic diseases, and daily sleep duration. Educational attainment was classified into seven categories, ranging from no formal education to graduate-level education or higher. Marital status was categorized as married (living with a spouse) or widowed, and living arrangement was classified as living alone or with family. Self-rated health was assessed using a 5-point Likert scale ranging from very good to very poor. Chronic diseases were recorded using a multiple-response questionnaire based on physician diagnoses. Daily sleep duration was calculated from self-reported bedtime to wake-up time, defined as the time participants resumed their usual daily activities the following morning.
Daily dietary intake was assessed using an artificial intelligence-assisted dietary camera system (DoingLab Inc., Korea), which captured photographs of all meals consumed throughout the study period (Park et al., 2024). Habitual physical activity was assessed using the short form of the International Physical Activity Questionnaire (IPAQ-SF) (Chun, 2012). Participants were provided with standardized activity diaries and instructed to record all daily physical activities during the intervention. Based on these records, the IPAQ-SF was completed weekly. Physical activity was quantified using the standardized IPAQ-SF scoring protocol by assigning metabolic equivalent (MET) values of 3.3, 4.0, and 8.0 to walking, moderate-intensity, and vigorous-intensity activities, respectively (Balboa-Castillo et al., 2023). Total physical activity was expressed as MET-hr per week, and the weekly values were averaged for statistical analysis.
Sarcopenia and body composition
Sarcopenia was assessed according to the AWGS guidelines (Chen et al., 2020). Calf circumference was measured bilaterally at the point of maximal girth using a nonelastic measuring tape without compressing the subcutaneous tissue, and the mean value was used for analysis. Low calf circumference was defined as <33 cm for women (Bonnefoy et al., 2002). Muscle strength was assessed using a grip dynamometer (TKK 5401, Takei, Japan). Participants performed two maximal trials with each hand while standing with the arm positioned approximately 30° from the trunk, and the average value was used for analysis. Low muscle strength was defined as grip strength <18 kg according to the AWGS criteria. Physical performance was evaluated using the 5×STS test, in which participants rose from a chair 5 consecutive times with their arms crossed over the chest. A completion time of ≥12 sec was considered indicative of poor physical performance. ASM was measured using dual-energy X-ray absorptiometry (DXA; Lunar Co., USA). Lean soft tissue mass of the upper and lower extremities was summed and normalized to height squared (kg/m2), with low ASM defined as <5.4 kg/m2 for women. Body weight, fat-free mass, and fat mass were also obtained from the DXA scan. Height was measured using a digital stadiometer, and body mass index (BMI) was calculated as body weight divided by height squared (Jo et al., 2026). Finally, the sarcopenia severity score was designed to represent the degree of severity by assigning a value of ‘1’ for the absence of sarcopenia, ‘2’ for the possible presence of sarcopenia, ‘3’ for a confirmed diagnosis of sarcopenia, and ‘4’ for severe sarcopenia.
Cardiopulmonary and SmO2 assessments during GXT
Before testing, participants rested in a seated position for 10 min to achieve physiological stabilization. Following the rest period, electrocardiographic electrodes were attached to the chest, an automated blood pressure cuff was placed on the right upper arm, and a respiratory gas-analysis mask connected to a metabolic cart was fitted and adjusted to ensure an airtight seal throughout the test. A NIRS sensor was positioned over the left vastus lateralis muscle, midway between the greater trochanter and the lateral femoral condyle. Sensor placement was standardized using anatomical landmarks and secured with an adhesive patch and elastic fixation strap to minimize movement artifacts and ambient light interference. Care was taken to maintain consistent skin contact without excessive pressure that could affect local blood flow or muscle oxygenation. To account for the potential influence of subcutaneous adipose tissue on SmO2 measurements, skinfold thickness at the sensor site was measured, recorded, and included in the analysis (Jo and Jee, 2026; Jo et al., 2026).
Cardiorespiratory fitness was assessed using a graded exercise test (GXT) based on the Bruce protocol, which consists of consecutive 3-min stages with progressive increases in treadmill speed and grade until volitional exhaustion (Vilela et al., 2023). The test began at 1.7 mph with a 10% incline, with standardized increases in speed and grade at each subsequent stage. Throughout the GXT, electrocardiographic activity, respiratory gas exchange, and SmO2 were monitored using a computerized metabolic analysis system, while heart rate and blood pressure were recorded simultaneously. Before testing, participants were instructed to indicate voluntary termination by raising their left arm when they were unable to continue because of fatigue or discomfort. The test was terminated at the participant’s request or when standard clinical termination criteria were met. Outcome measures included VO2max, maximal MET (METmax), maximal respiratory frequency (Rfmax), maximal ventilation (VEmax), resting or maximal heart rate (HRrest or HRmax), resting or maximal systolic blood pressure (SBPrest or SBPmax), and resting or maximal rate-pressure product (RPPrest or RPPmax), calculated as HR×SBP as an index of myocardial oxygen demand. Changes in vastus lateralis SmO2 were also evaluated to assess peripheral muscle oxygenation during exercise. All GXT assessments were performed by certified exercise specialists before and after the 8-week intervention.
Statistical analyses
All statistical analyses were conducted using IBM SPSS Statistics ver. 27.0 (IBM Corp., USA) and GraphPad Prism version 11 (GraphPad Software, USA). Continuous variables are reported as means±standard deviations, and categorical variables are presented as frequencies and percentages. Group differences in categorical variables were examined using the χ2 test or Fisher exact test. Given the relatively small sample size of this pilot study, the distribution of all outcome variables was carefully examined using the Shapiro –Wilk test. Because several variables deviated from normality, parametric repeated-measures analyses were considered inappropriate. Therefore, percentage changes (Δ%) from baseline to postintervention were calculated for each participant, and differences in these changes among the CON, TEG, and SEG were analyzed using the Kruskal–Wallis test. This nonparametric approach was selected to reduce reliance on distributional assumptions in the analysis of the small pilot sample. Effect sizes were interpreted using η2, with values of 0.01, 0.06, and 0.14 indicating small, medium, and large effects, respectively (Cohen, 1992). Statistical significance was set at P≤0.05 for all analyses.
RESULTS
Demographic and anthropometric characteristics
As shown in Table 1, no statistically significant differences were observed among the groups for any demographic or anthropometric variable, indicating that the three groups were comparable before the intervention. Among the 30 participants, most reported at least one diagnosed condition (26, 86.7%), and more than half reported two or more conditions (17, 56.7%). Obesity, hyperlipidemia, and hypertension were the most frequently reported conditions (7, 23.3% each) as shown in Table 2. In CON, hyperlipidemia and hypertension were the most common conditions (3, 30.0% each), whereas arthritis was the most common in SEG (3, 30.0%). In TEG, obesity was the most prevalent condition (4, 40.0%), followed by hyperlipidemia and diabetes mellitus (3, 30.0% each). The mean number of conditions per participant was not significantly different (H=1.214; P=0.545).
Table 1.
Demographic and anthropometric features among the groups
| Variable | CON (n=10) | TEG (n=10) | SEG (n=10) | Kruskal–Wallis | η 2 | |
|---|---|---|---|---|---|---|
|
|
|
|
|
|||
| Mean±SD | Mean±SD | Mean±SD | H | P-value | ||
| Demographic | ||||||
| Age (yr) | 51.5±4.0 | 50.2±6.6 | 49.2±3.5 | 1.320 | 0.517 | 0.039 |
| Education level | 4.3±0.5 | 4.7±0.9 | 4.4±1.0 | 0.711 | 0.701 | 0.045 |
| Marital status | 1.2±0.4 | 1.5±0.5 | 1.3±0.5 | 2.030 | 0.362 | 0.070 |
| Living arrangement | 1.7±0.5 | 1.2±0.4 | 1.3±0.5 | 5.639 | 0.060 | 0.194 |
| Self-rated health status | 2.1±1.1 | 3.2±0.8 | 2.8±0.9 | 5.385 | 0.068 | 0.205 |
| Sleep duration (hr) | 6.6±0.7 | 6.6±0.8 | 6.5±0.7 | 0.461 | 0.794 | 0.006 |
| Daily meals (kcal) | 1,602.7±204.7 | 1,612.7±138.4 | 1,671.3±304.4 | 0.072 | 0.965 | 0.019 |
| Weekly activity (MET-hr/wk) | 11.5±4.6 | 12.7±6.1 | 9.9±3.0 | 1.458 | 0.482 | 0.063 |
|
| ||||||
| Anthropometric | ||||||
| Height (m) | 1.6±0.1 | 1.6±0.0 | 1.6±0.1 | 1.059 | 0.589 | 0.022 |
| Body weight (kg) | 54.4±8.8 | 55.3±5.9 | 56.8±6.2 | 1.116 | 0.572 | 0.021 |
| Body mass index (kg/m2) | 21.5±2.6 | 22.0±2.5 | 23.1±2.1 | 2.910 | 0.233 | 0.073 |
| Fat mass (kg) | 12.7±3.3 | 12.5±2.2 | 13.7±2.7 | 1.779 | 0.411 | 0.040 |
| Muscle mass (kg) | 21.8±3.9 | 22.9±2.5 | 23.3±2.5 | 2.041 | 0.360 | 0.044 |
CON, control group; TEG, treadmill exercise group; SEG, step exercise group; MET, metabolic equivalent.
Table 2.
Self-reported diagnosed conditions by group
| Condition | CON (n=10) | TEG (n=10) | SEG (n=10) | Total (N=30) |
|---|---|---|---|---|
| Obesity | 2 (20.0) | 1 (10.0) | 4 (40.0) | 7 (23.3) |
| Ear, nose, and throat disorders | 2 (20.0) | 2 (20.0) | 2 (20.0) | 6 (20.0) |
| Endocrine disorders | 2 (20.0) | 2 (20.0) | 2 (20.0) | 6 (20.0) |
| Urological disorders | 1 (10.0) | 1 (10.0) | 2 (20.0) | 4 (13.3) |
| Hyperlipidemia | 3 (30.0) | 1 (10.0) | 3 (30.0) | 7 (23.3) |
| Liver disease | 1 (10.0) | 1 (10.0) | 1 (10.0) | 3 (10.0) |
| Osteoporosis | 2 (20.0) | 1 (10.0) | 1 (10.0) | 4 (13.3) |
| Hypertension | 3 (30.0) | 2 (20.0) | 2 (20.0) | 7 (23.3) |
| Diabetes mellitus | 1 (10.0) | 1 (10.0) | 3 (30.0) | 5 (16.7) |
| Arthritis | 1 (10.0) | 3 (30.0) | 1 (10.0) | 5 (16.7) |
| Total number of conditions | 18 | 15 | 21 | 54 |
| Number of conditions per participant | 1.80±1.32 | 1.50±0.97 | 2.10±1.29 | - |
| Participants with ≥1 condition | 8 (80.0) | 9 (90.0) | 9 (90.0) | 26 (86.7) |
| Participants with ≥2 conditions | 6 (60.0) | 4 (40.0) | 7 (70.0) | 17 (56.7) |
Values are represented as mean±standard deviation.
CON, control group; TEG, treadmill exercise group; SEG, step exercise group.
These findings indicate that the three groups were well matched at baseline with respect to demographic characteristics, habitual lifestyle factors, and body composition.
Changes in sarcopenia and body composition variables
As shown in Table 3, at baseline, no significant between-group differences were observed for calf circumference, grip strength, ASM, sarcopenia severity, body weight, BMI, fat mass, or muscle mass. Although baseline performance on the 5×STS test approached significance, no statistically significant difference was detected among the groups. Following the intervention, significant between-group differences were observed for all sarcopenia-related variables. Compared with the CON and TEG, the SEG demonstrated significantly greater calf circumference, grip strength, faster 5×STS performance, and higher ASM. In addition, the sarcopenia severity score differed significantly between the SEG and CON.
Table 3.
Changes in sarcopenia and body composition variables
| Item | Time | CON (n=10) | TEG (n=10) | SEG (n=10) | Kruskal–Wallis | η 2 | |
|---|---|---|---|---|---|---|---|
|
|
|
|
|
||||
| Mean±SD | Mean±SD | Mean±SD | H | P-value | |||
| Sarcopenic variable | |||||||
| Calf circumference (cm) | Pre | 27.9±3.6 | 25.4±4.4 | 28.3±3.0 | 4.485 | 0.106 | 0.120 |
| Post | 25.1±2.9 | 24.8±4.4 | 31.0±3.0 | 13.087 | 0.001 | 0.422 | |
| Δ% | −8.6±16.6 | −1.8±9.1 | 9.7±6.3 | 9.591 | 0.008 | 0.324 | |
| Grip strength (kg) | Pre | 17.7±2.9 | 17.2±3.6 | 17.1±2.8 | 0.742 | 0.690 | 0.009 |
| Post | 14.2±1.8 | 16.4±2.7 | 18.3±2.1 | 11.406 | 0.003 | 0.393 | |
| Δ% | −18.4±15.1 | −3.3±10.8 | 9.4±17.5 | 10.990 | 0.004 | 0.399 | |
| 5×STS (sec) | Pre | 15.1±2.1 | 16.4±0.8 | 15.3±2.3 | 5.776 | 0.056 | 0.103 |
| Post | 17.1±2.0 | 15.2±2.6 | 11.4±1.0 | 18.862 | 0.001 | 0.617 | |
| Δ% | 14.9±15.0 | −7.3±18.7 | −24.2±12.1 | 16.179 | 0.001 | 0.544 | |
| ASM (kg/m2) | Pre | 5.4±0.6 | 5.0±0.2 | 5.2±0.6 | 3.530 | 0.171 | 0.126 |
| Post | 5.0±0.7 | 5.6±0.7 | 5.9±1.0 | 6.164 | 0.046 | 0.194 | |
| Δ% | −7.4±12.7 | 12.7±13.6 | 15.6±27.2 | 9.080 | 0.011 | 0.243 | |
|
| |||||||
| Sarcopenic severity | Pre | 3.4±1.0 | 3.2±0.6 | 3.4±1.0 | 1.174 | 0.556 | 0.013 |
| Post | 3.8±0.4 | 2.8±0.9 | 2.7±0.9 | 9.028 | 0.011 | 0.300 | |
| Δ% | 22.5±44.8 | −13.3±17.2 | −15.0±33.7 | 5.967 | 0.050 | 0.225 | |
|
| |||||||
| Body composition | |||||||
| Body weight (kg) | Pre | 54.4±8.8 | 55.3±5.9 | 56.8±6.2 | 1.116 | 0.572 | 0.021 |
| Post | 56.4±9.8 | 54.0±5.8 | 55.4±5.6 | 0.361 | 0.835 | 0.019 | |
| Δ% | 3.5±5.1 | −2.3±4.3 | −2.4±3.1 | 7.834 | 0.02 | 0.318 | |
| Body mass index (kg/m2) | Pre | 21.5±2.6 | 22.0±2.5 | 23.1±2.1 | 2.910 | 0.233 | 0.073 |
| Post | 22.3±3.1 | 21.7±1.9 | 22.1±1.7 | 0.638 | 0.727 | 0.014 | |
| Δ% | 3.4±5.3 | −1.4±6.3 | −4.1±4.2 | 7.464 | 0.024 | 0.276 | |
| Fat mass (kg) | Pre | 12.7±3.3 | 12.5±2.2 | 13.7±2.7 | 1.779 | 0.411 | 0.04 |
| Post | 13.7±3.6 | 12.5±2.1 | 13.3±2.2 | 0.750 | 0.687 | 0.034 | |
| Δ% | 8.5±8.9 | 0.7±6.8 | −2.3±5.2 | 8.877 | 0.012 | 0.315 | |
| Muscle mass (kg) | Pre | 21.8±3.9 | 22.9±2.5 | 23.3±2.5 | 2.041 | 0.360 | 0.044 |
| Post | 20.8±4.0 | 22.9±2.4 | 24.2±2.1 | 6.838 | 0.033 | 0.199 | |
| Δ% | −5.0±4.5 | 0.0±5.3 | 4.3±4.5 | 12.587 | 0.002 | 0.410 | |
Values are represented as mean±standard deviation.
CON, control group; TEG, treadmill exercise group; SEG, step exercise group; 5×STS, five-times sit-to-stand; ASM, appendicular skeletal muscle mass.
Specifically, no significant difference in sarcopenia severity was observed among the CON, TEG, and SEG, indicating comparable baseline disease severity across the three groups. Following the 8-week intervention, a significant between-group difference was observed. The CON exhibited the highest sarcopenia severity score, whereas both exercise groups demonstrated lower severity scores, indicating that participation in either treadmill or step exercise attenuated the progression of sarcopenia compared with the nonexercising CON. Analysis of Δ% demonstrated that sarcopenia severity increased in the CON, whereas it decreased in the TEG and SEG. Although the between-group difference in Δ% did not reach statistical significance, the effect size was relatively large, suggesting a meaningful intervention effect that may not have been fully detected because of the limited sample size of this pilot study (Fig. 2).
Fig. 2.

Changes and differences in sarcopenic degree among groups. CON, control group; TEG, treadmill exercise group; SEG, step exercise group. *P≤0.05.
Furthermore, analysis of Δ% demonstrated significant between-group differences in calf circumference, grip strength, 5×STS performance, ASM, and muscle mass. The SEG exhibited the greatest improvements, showing increases in calf circumference, grip strength, ASM, and muscle mass, together with the largest reduction in 5×STS completion time. In contrast, the CON demonstrated deterioration across most sarcopenia indicators, including reductions in calf circumference, grip strength, ASM, and muscle mass, accompanied by a prolonged 5×STS. Regarding body composition, no statistically significant between-group differences were observed for postintervention body weight, BMI, or fat mass. Likewise, percentage changes in body weight, BMI, and fat mass did not reach statistical significance. However, postintervention muscle mass differed significantly among the groups, with the SEG demonstrating the most favorable change.
Changes in cardiopulmonary and hemodynamic variables
As shown in Table 4, no significant between-group differences were observed in cardiopulmonary or haemodynamic variables at baseline. Following the intervention, VO2max, METmax, maximal heart rate, and resting rate–pressure product differed significantly among groups. The SEG showed the highest post-intervention VO2max and METmax and the lowest RPPrest. Percentage changes in VO2max, METmax, Rfmax, and VEmax differed significantly among groups. These variables decreased in the CON and increased in both exercise groups, with the SEG showing the greatest numerical increases. Percentage changes in SBPrest and SBPmax and RPPrest also differed significantly among groups. These variables increased in the CON and decreased in both exercise groups. In contrast, percentage changes in HRrest, HRmax, and RPPmax did not differ significantly among groups.
Table 4.
Changes in cardiopulmonary and hemodynamic variables
| Item | Time | CON (n=10) | TEG (n=10) | SEG (n=10) | Kruskal–Wallis | η 2 | |
|---|---|---|---|---|---|---|---|
|
|
|
|
|
||||
| Mean±SD | Mean±SD | Mean±SD | H | P-value | |||
| VO2max (mL/kg/min) | Pre | 27.6±2.3 | 29.2±4.9 | 27.5±5.5 | 0.792 | 0.673 | 0.034 |
| Post | 24.1±2.1 | 31.1±4.0 | 32.7±3.9 | 16.088 | 0.001 | 0.571 | |
| Δ% | −12.5±6.5 | 7.3±7.2 | 22.1±24.2 | 23.280 | 0.001 | 0.497 | |
|
| |||||||
| METmax | Pre | 7.9±0.7 | 8.4±1.4 | 7.9±1.6 | 0.901 | 0.637 | 0.035 |
| Post | 6.9±0.6 | 8.9±1.1 | 9.4±1.1 | 16.227 | 0.001 | 0.571 | |
| Δ% | −12.5±6.5 | 7.3±7.2 | 22.1±24.2 | 23.280 | 0.001 | 0.497 | |
|
| |||||||
| Rfmax (reps) | Pre | 39.9±5.7 | 40.5±5.1 | 42.6±6.4 | 0.886 | 0.642 | 0.044 |
| Post | 38.7±6.5 | 43.5±5.1 | 46.6±6.4 | 5.920 | 0.052 | 0.244 | |
| Δ% | −3.3±4.2 | 7.6±1.0 | 9.6±1.4 | 23.216 | 0.001 | 0.837 | |
|
| |||||||
| VEmax (L/min) | Pre | 87.0±13.5 | 94.4±28.9 | 90.1±29.5 | 0.286 | 0.867 | 0.016 |
| Post | 83.4±13.8 | 102.4±30.4 | 111.1±32.5 | 4.355 | 0.113 | 0.171 | |
| Δ% | −4.2±4.2 | 8.8±1.2 | 25.9±25.5 | 24.827 | 0.001 | 0.430 | |
|
| |||||||
| HRrest (beat/min) | Pre | 82.9±11.0 | 82.3±10.1 | 85.4±7.2 | 0.241 | 0.886 | 0.021 |
| Post | 84.6±8.2 | 78.3±9.1 | 78.8±6.8 | 2.954 | 0.228 | 0.121 | |
| Δ% | 3.8±18.7 | −4.2±11.6 | −7.8±0.6 | 3.691 | 0.158 | 0.141 | |
|
| |||||||
| HRmax (beat/min) | Pre | 168.5±4.0 | 169.8±6.6 | 170.8±3.5 | 1.320 | 0.517 | 0.039 |
| Post | 166.8±6.2 | 170.5±6.1 | 173.0±4.0 | 8.072 | 0.018 | 0.193 | |
| Δ% | −1.0±4.8 | 0.4±2.8 | 1.3±1.7 | 2.442 | 0.295 | 0.078 | |
|
| |||||||
| SBPrest (mmHg) | Pre | 134.8±14.6 | 134.3±13.6 | 134.4±19.3 | 0.321 | 0.852 | 0.001 |
| Post | 137.4±11.6 | 129.9±13.6 | 126.4±14.9 | 3.682 | 0.159 | 0.115 | |
| Δ% | 2.2±3.9 | −3.1±6.6 | −5.3±7.6 | 12.404 | 0.002 | 0.223 | |
|
| |||||||
| SBPmax (mmHg) | Pre | 189.4±27.4 | 192.2±22.8 | 190.4±32.3 | 0.098 | 0.952 | 0.002 |
| Post | 191.6±26.8 | 191.2±23.1 | 189.4±31.4 | 0.204 | 0.903 | 0.001 | |
| Δ% | 1.2±0.2 | −0.5±0.1 | −0.6±0.2 | 20.375 | 0.004 | 0.979 | |
|
| |||||||
| RPPrest (×103 bpm·mmHg) | Pre | 11.19±1.94 | 11.00±1.29 | 11.44±1.62 | 0.529 | 0.768 | 0.014 |
| Post | 11.65±1.67 | 10.11±1.06 | 9.97±1.52 | 6.111 | 0.047 | 0.239 | |
| Δ% | 6.0±19.2 | −7.6±9.1 | −12.7±7.3 | 10.312 | 0.006 | 0.292 | |
|
| |||||||
| RPPmax (×103 bpm·mmHg) | Pre | 31.93±4.80 | 32.61±3.76 | 32.51±5.32 | 0.080 | 0.961 | 0.005 |
| Post | 31.87±4.15 | 32.61±4.18 | 32.73±5.28 | 0.302 | 0.860 | 0.008 | |
| Δ% | 0.2±5.0 | −0.1±2.8 | 0.7±1.7 | 1.541 | 0.463 | 0.010 | |
Values are represented as mean±standard deviation.
CON, control group; TEG, treadmill exercise group; SEG, step exercise group; VO2max, maximal oxygen uptake; MET, metabolic equivalent; Rf, respiratory frequency; VE, ventilation; HR, heart rate; SBP, systolic blood pressure; RPP, rate-pressure product.
Changes in SmO2, total hemoglobin, and skinfold thickness at GXT
As shown in Table 5, at baseline, no significant between-group differences were observed for resting SmO2 (SmO2rest), maximal exercise SmO2 (SmO2max), total hemoglobin (tHb), or skinfold thickness. Following the intervention, SmO2max differed significantly among groups, with the lowest value observed in the SEG, followed by the TEG and CON. Percentage changes in SmO2max also differed significantly among groups, showing an increase in the CON and decreases in both exercise groups, with the greatest numerical reduction in the SEG. Neither resting SmO2 nor total haemoglobin differed significantly among groups at post-intervention or in percentage changes. Skinfold thickness showed significant between-group differences at post-intervention and in percentage changes, with the SEG exhibiting the greatest numerical percentage increase.
Table 5.
Changes in SmO2, tHb, and skinfold thickness before and after the graded exercise test
| Items | Time | CON (n=10) | TEG (n=10) | SEG (n=10) | Kruskal–Wallis | η 2 | |
|---|---|---|---|---|---|---|---|
|
|
|
|
|
||||
| Mean±SD | Mean±SD | Mean±SD | H | P-value | |||
| SmO2 rest (%) | Pre | 58.6±13.6 | 53.9±10.7 | 60.1±10.8 | 1.358 | 0.507 | 0.053 |
| Post | 56.9±14.5 | 58.6±9.8 | 66.8±11.1 | 3.589 | 0.166 | 0.127 | |
| Δ% | 1.5±32.2 | 12.2±28.7 | 12.7±18.7 | 1.918 | 0.383 | 0.038 | |
|
| |||||||
| SmO2 max (%) | Pre | 44.0±9.8 | 41.7±9.8 | 41.6±11.1 | 0.328 | 0.849 | 0.013 |
| Post | 48.7±9.1 | 37.7±9.6 | 30.6±8.9 | 11.781 | 0.003 | 0.421 | |
| Δ% | 11.8±9.4 | −9.6±9.1 | −22.1±29.6 | 11.647 | 0.003 | 0.384 | |
|
| |||||||
| tHb (g/dL) | Pre | 19.2±4.7 | 16.8±2.8 | 19.4±5.9 | 1.269 | 0.530 | 0.066 |
| Post | 18.5±3.6 | 17.3±3.8 | 19.4±4.3 | 2.181 | 0.336 | 0.053 | |
| Δ% | −1.5±12.4 | 2.6±8.3 | 5.6±31.1 | 2.361 | 0.307 | 0.023 | |
|
| |||||||
| Skinfold thickness (mm) | Pre | 12.5±0.5 | 12.2±0.3 | 12.5±0.6 | 3.329 | 0.189 | 0.060 |
| Post | 12.7±0.2 | 12.3±0.3 | 12.8±0.4 | 10.790 | 0.005 | 0.342 | |
| Δ% | 1.9±6.2 | 0.7±0.7 | 3.0±3.7 | 7.397 | 0.025 | 0.052 | |
Values are represented as mean±standard deviation.
CON, control group; TEG, treadmill exercise group; SEG, step exercise group; SmO2, skeletal muscle oxygen saturation; tHb, total hemoglobin.
SmO2 during the 30-min intervention session
Fig. 3 presents the changes in vastus lateralis SmO2 during the GXT following the 8-week intervention. At baseline, resting SmO2 did not differ significantly among the CON, TEG, and SEG. Likewise, no significant between-group differences were observed during the early stages of exercise (levels 1–3; all P>0.05). From level 4 onward, significant between-group differences emerged and became progressively larger as exercise intensity increased. The corresponding effect sizes increased progressively from η2=0.198 at level 4 to η2=0.388 at level 10. At the highest exercise intensity (level 10), the TEG exhibited the lowest SmO2, followed by the SEG, whereas the CON maintained the highest value. During the recovery phase, SmO2 rapidly returned toward baseline levels in all groups, with no significant between-group difference.
Fig. 3.

Changes and differences in muscle oxygen saturation at level 10 among groups. SmO2, skeletal muscle oxygen saturation; CON, control group; TEG, treadmill exercise group; SEG, step exercise group. *P≤0.05. **P≤0.01.
DISCUSSION
The present pilot randomized controlled trial investigated the effects of an 8-week progressive step exercise program on sarcopenia-related outcomes, cardiorespiratory fitness, and peripheral muscle oxygenation in middle-aged women with sarcopenia. The principal findings were as follows: (1) step exercise produced greater improvements in calf circumference, grip strength, ASM, muscle mass, and lower-extremity functional performance than treadmill walking and the control condition; (2) step exercise elicited superior improvements in cardiorespiratory fitness, including VO2max, METmax, ventilatory responses, and resting cardiovascular function; and (3) SmO2 demonstrated marked reductions during high-intensity exercise after training, suggesting enhanced peripheral oxygen extraction and skeletal muscle oxidative capacity.
Sarcopenia is an age-related condition characterized by progressive declines in skeletal muscle mass and function and is highly prevalent among older adults. Because it is associated with impaired quality of life, disability, and increased mortality, greater clinical awareness is needed to facilitate its timely and accurate identification in both community-based and geriatric care settings (Marzetti et al., 2017). Current international guidelines emphasize that improvements in muscle strength and physical function are primary therapeutic targets because they are more strongly associated with adverse clinical outcomes than muscle mass alone (Chen et al., 2020). In the present study, participants in the SEG demonstrated significant improvements in calf circumference, grip strength, ASM, muscle mass, and the 5×STS test, whereas the CON exhibited deterioration across most sarcopenia-related outcomes. In particular, the 24.2% reduction in 5×STS function represents a clinically meaningful enhancement in lower-extremity function because chair-rise performance is closely associated with mobility, fall risk, and independence in older adults (Chen et al., 2020). These findings suggest that progressive step exercise effectively attenuates functional decline while simultaneously promoting skeletal muscle adaptation.
The greater improvement observed following step exercise is likely attributable to its unique biomechanical characteristics. Unlike level walking, repeated stepping requires individuals to elevate their body mass against gravity, thereby increasing mechanical loading of the lower-extremity musculature (Lay et al., 2006; Teh and Aziz, 2002). The repeated concentric contractions during ascent and eccentric contractions during descent provide a greater neuromuscular stimulus than level walking, resulting in enhanced muscle recruitment and force production (Jo and Jee, 2026; Jo et al., 2026). Previous investigations have similarly demonstrated that step-based exercise improves lower-limb strength, balance, gait performance, and functional mobility (Boreham et al., 2000; Teh and Aziz, 2002). The present findings extend this evidence by demonstrating improvements in both skeletal muscle quantity (ASM and muscle mass) and muscle function in women with sarcopenia.
Cardiorespiratory fitness also improved substantially following step exercise. Participants in the SEG demonstrated a 22.1% increase in VO2max and METmax, accompanied by improvements in ventilatory responses and reductions in HRrest and RPPrest. VO2max is considered the gold-standard indicator of aerobic fitness and is strongly associated with cardiovascular health, mobility, and survival (Kodama et al., 2009). Moghadam et al. (2020) reported that improvements in aerobic capacity are closely associated with enhanced physical performance and reduced frailty among individuals with sarcopenia. The favourable adaptations observed following step exercise may be related to its greater mechanical and metabolic demands. Repeated stepping requires elevation of body mass against gravity and greater lower-extremity muscle recruitment, which may promote skeletal muscle adaptation while simultaneously increasing cardiovascular demand. These combined stimuli may contribute to improvements in VO2max and peripheral oxygen utilization. The lower exercise SmO2 observed after training may further reflect enhanced oxygen extraction by active skeletal muscle, supporting improved peripheral oxidative capacity.
An important strength of the present study is the inclusion of NIRS-derived SmO2 as an objective indicator of peripheral skeletal muscle adaptation. Unlike conventional cardiopulmonary measurements that primarily reflect systemic physiological responses, SmO2 provides direct information regarding local oxygen delivery, oxygen extraction, and mitochondrial oxidative metabolism within active skeletal muscle (Perrey and Ferrari, 2018). Following the intervention, resting SmO2 remained relatively unchanged among the groups, whereas maximal exercise SmO2 decreased significantly in the exercise groups, particularly in the SEG. Importantly, reductions in exercise SmO2 should not be interpreted as impaired oxygenation. Rather, lower SmO2 during exercise reflects greater oxygen extraction by working skeletal muscle and therefore represents improved peripheral metabolic efficiency (Grassi et al., 2015). Previous physiological studies have demonstrated that endurance training increases mitochondrial density, capillary supply, and oxidative enzyme activity, thereby enhancing muscular oxygen utilization despite similar oxygen delivery (Grassi et al., 2015; Jones et al., 2019). The present findings are consistent with these mechanisms and suggest that step exercise enhanced peripheral oxidative capacity to a greater extent than the control condition.
The stage-by-stage analysis of SmO2 during the GXT provides additional physiological insight. No between-group differences were observed during rest or the early stages of exercise; however, significant differences emerged from level 4 onward and progressively increased as exercise intensity rose. This pattern indicates that training-induced peripheral adaptations become apparent only after oxygen demand exceeds a moderate metabolic threshold. At higher exercise intensities, trained skeletal muscle requires greater oxygen extraction to sustain adenosine triphosphate production through oxidative phosphorylation, resulting in lower SmO2 values despite improved exercise capacity (Perrey and Ferrari, 2018). The progressively increasing effect sizes from levels 4 to 10 further support the hypothesis that step exercise preferentially enhances peripheral muscle efficiency under higher physiological stress.
Interestingly, the TEG exhibited the lowest SmO2 at the highest exercise stage, whereas the SEG demonstrated the greatest improvements in VO2max and sarcopenia-related outcomes. This apparent discrepancy may reflect differences in muscle recruitment patterns between the two exercise modalities. Treadmill walking predominantly activates the vastus lateralis during continuous locomotion, whereas step exercise distributes the workload across multiple lower-extremity muscle groups, including the gluteus maximus, quadriceps, hamstrings, and plantar flexors. Consequently, local oxygen desaturation in the vastus lateralis may be greater during treadmill exercise, whereas whole-body metabolic adaptation is enhanced to a greater extent following step exercise. This interpretation is consistent with previous biomechanical studies demonstrating greater multijoint muscle activation during stair or step exercise than during level walking (Lay et al., 2006).
Although significant improvements were observed for most physiological outcomes, body weight, BMI, and fat mass changed only modestly. This finding suggests that exercise training preferentially improved muscle-related outcomes without substantial changes in total body mass or adiposity during the relatively short intervention period. Similar observations have been reported in previous sarcopenia studies, in which improvements in muscle function preceded measurable changes in body composition (Fragala et al., 2019; Moghadam et al., 2020).
This study has several limitations. First, as a pilot study with a relatively small sample size, statistical power was limited for detecting small-to-moderate effects, particularly for variables such as percentage changes in sarcopenia severity. Nevertheless, several outcomes demonstrated moderate-to-large effect sizes, suggesting clinically meaningful intervention effects that warrant confirmation in larger randomized controlled trials. Second, only women aged 41–58 years were included; therefore, the findings cannot be generalized to men or older populations. Third, SmO2 was measured only in the vastus lateralis, although step exercise involves coordinated activation of several lower-extremity muscle groups. Future studies incorporating multisite NIRS measurements and electromyography may provide a more comprehensive understanding of exercise-induced peripheral adaptations. Finally, the intervention period was limited to 8 weeks; longer follow-up studies are required to determine whether these physiological adaptations are maintained over time.
In conclusion, the present pilot study demonstrates that progressive step exercise is an effective intervention for improving sarcopenic indicators, cardiorespiratory fitness, and peripheral muscle oxidative function in women with sarcopenia. Compared with treadmill walking, step exercise produced greater improvements in lower-extremity function, skeletal muscle mass, aerobic capacity, and exercise-induced muscle oxygen utilization. These preliminary findings suggest that step exercise may provide greater benefits than treadmill exercise for sarcopenia-related outcomes, cardiorespiratory fitness, and muscle oxygen utilization. However, given the small sample size and pilot nature of the study, these findings should be interpreted cautiously and confirmed in larger, adequately powered randomized controlled trials.
Funding Statement
This research was conducted with the support of an intramural research grant from Hanseo University in 2026.
Footnotes
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
ACKNOWLEDGMENTS
This research was conducted with the support of an intramural research grant from Hanseo University in 2026.
REFERENCES
- Baggen RJ, Van Roie E, Verschueren SM, Van Driessche S, Coudyzer W, van Dieën JH, Delecluse C. Bench stepping with incremental heights improves muscle volume, strength and functional performance in older women. Exp Gerontol. 2019;120:6–14. doi: 10.1016/j.exger.2019.02.013. [DOI] [PubMed] [Google Scholar]
- Balboa-Castillo T, Muñoz S, Serón P, Andrade-Mayorga O, Lavados-Romo P, Aguilar-Farias N. Validity and reliability of the international physical activity questionnaire short form in Chilean adults. PLoS One. 2023;18:e0291604. doi: 10.1371/journal.pone.0291604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12 doi: 10.1371/journal.pone.0169548.e0169548 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bonnefoy M, Jauffret M, Kostka T, Jusot JF. Usefulness of calf circumference measurement in assessing the nutritional state of hospitalized elderly people. Gerontology. 2002;48:162–169. doi: 10.1159/000052836. [DOI] [PubMed] [Google Scholar]
- Boreham CA, Wallace WF, Nevill A. Training effects of accumulated daily stair-climbing exercise in previously sedentary young women. Prev Med. 2000;30:277–281. doi: 10.1006/pmed.2000.0634. [DOI] [PubMed] [Google Scholar]
- Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–381. [PubMed] [Google Scholar]
- Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300–307.e2. doi: 10.1016/j.jamda.2019.12.012. [DOI] [PubMed] [Google Scholar]
- Chun MY. Validity and reliability of Korean version of international physical activity questionnaire short form in the elderly. Korean J Fam Med. 2012;33:144–151. doi: 10.4082/kjfm.2012.33.3.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen J. A power primer. Psychol Bull. 1992;112:155–159. doi: 10.1037//0033-2909.112.1.155. [DOI] [PubMed] [Google Scholar]
- Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2 Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. doi: 10.1093/ageing/afy169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, Lancaster GA, PAFS consensus group CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239. doi: 10.1136/bmj.i5239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fragala MS, Cadore EL, Dorgo S, Izquierdo M, Kraemer WJ, Peterson MD, Ryan ED. Resistance training for older adults: position statement from the National Strength and Conditioning Association. J Strength Cond Res. 2019;33:2019–2052. doi: 10.1519/JSC.0000000000003230. [DOI] [PubMed] [Google Scholar]
- Ghosal AM, Chandrasekaran B. Stair-climbing interventions on cardio-metabolic outcomes in adults: a scoping review. J Taibah Univ Med Sci. 2023;19:136–150. doi: 10.1016/j.jtumed.2023.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grassi B, Rossiter HB, Zoladz JA. Skeletal muscle fatigue and decreased efficiency: two sides of the same coin? Exerc Sport Sci Rev. 2015;43:75–83. doi: 10.1249/JES.0000000000000043. [DOI] [PubMed] [Google Scholar]
- Jenkins EM, Nairn LN, Skelly LE, Little JP, Gibala MJ. Do stair climbing exercise “snacks” improve cardiorespiratory fitness? Appl Physiol Nutr Metab. 2019;44:681–684. doi: 10.1139/apnm-2018-0675. [DOI] [PubMed] [Google Scholar]
- Jo SG, Jee YS. Differential hemodynamic adaptations to identical body conditioning program across blood pressure categories: a quasi-experimental study. J Exerc Rehabil. 2026;22:51–61. doi: 10.12965/jer.2652192.096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jo SG, Yoo DH, Jee YS. Monitoring muscle oxygen saturation during forest trail hiking: a prospective open-label quasi-experimental study with facility-based allocation examining physiological and immunological responses in older adults. Sci Rep. 2026;16:19824. doi: 10.1038/s41598-026-49821-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones AM, Burnley M, Black MI, Poole DC, Vanhatalo A. The maximal metabolic steady state: redefining the ‘gold standard’. Physiol Rep. 2019;7:e14098. doi: 10.14814/phy2.14098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim TN, Choi KM. Sarcopenia: definition, epidemiology, and pathophysiology. J Bone Metab. 2013;20:1–10. doi: 10.11005/jbm.2013.20.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, Sugawara A, Totsuka K, Shimano H, Ohashi Y, Yamada N, Sone H. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301:2024–2035. doi: 10.1001/jama.2009.681. [DOI] [PubMed] [Google Scholar]
- Lahade S, Ross N, O’Sullivan TD. Advances in fully integrated wearable near-infrared spectroscopy: hardware innovations and biomedical applications. J Phys Photonics. 2026;8:022004. doi: 10.1088/2515-7647/ae6ae4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Landi F, Cruz-Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, Bernabei R, Onder G. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing. 2013;42:203–209. doi: 10.1093/ageing/afs194. [DOI] [PubMed] [Google Scholar]
- Lay AN, Hass CJ, Gregor RJ. The effects of sloped surfaces on locomotion: a kinematic and kinetic analysis. J Biomech. 2006;39:1621–1628. doi: 10.1016/j.jbiomech.2005.05.005. [DOI] [PubMed] [Google Scholar]
- Marzetti E, Calvani R, Tosato M, Cesari M, Di Bari M, Cherubini A, Collamati A, D’Angelo E, Pahor M, Bernabei R, Landi F, SPRINTT Consortium Sarcopenia: an overview. Aging Clin Exp Res. 2017;29:11–17. doi: 10.1007/s40520-016-0704-5. [DOI] [PubMed] [Google Scholar]
- Moghadam BH, Bagheri R, Ashtary-Larky D, Tinsley GM, Eskandari M, Wong A, Moghadam BH, Kreider RB, Baker JS. The effects of concurrent training order on satellite cell-related markers, body composition, muscular and cardiorespiratory fitness in older men with sarcopenia. J Nutr Health Aging. 2020;24:796–804. doi: 10.1007/s12603-020-1431-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Park S, Kim Y, Jee Y. Plank exercise improves respiratory capacity through positive changes in body composition, abdominis function, and autonomic nerves’ activities. Eur J Sport Sci. 2024;24:330–340. [Google Scholar]
- Perrey S, Ferrari M. Muscle oximetry in sports science: a systematic review. Sports Med. 2018;48:597–616. doi: 10.1007/s40279-017-0820-1. [DOI] [PubMed] [Google Scholar]
- Teh KC, Aziz AR. Heart rate, oxygen uptake, and energy cost of ascending and descending the stairs. Med Sci Sports Exerc. 2002;34:695–699. doi: 10.1097/00005768-200204000-00021. [DOI] [PubMed] [Google Scholar]
- Thompson PD, Arena R, Riebe D, Pescatello LS, American College of Sports Medicine ACSM’s new preparticipation health screening recommendations from ACSM’s guidelines for exercise testing and prescription, ninth edition. Curr Sports Med Rep. 2013;12:215–217. doi: 10.1249/JSR.0b013e31829a68cf. [DOI] [PubMed] [Google Scholar]
- Van Roie E, van Uffelen J, Delecluse C. Stair-climbing versus machine-based resistance exercise to improve muscle power among older adults: a noninferiority trial. J Strength Cond Res. 2025;39:e496–e505. doi: 10.1519/JSC.0000000000005005. [DOI] [PubMed] [Google Scholar]
- Vilela EM, Oliveira C, Oliveira C, Torres S, Sampaio F, Primo J, Ribeiro J, Teixeira M, Oliveira M, Bettencourt N, Viamonte S, Fontes-Carvalho R. Sixty years of the Bruce protocol: reappraising the contemporary role of exercise stress testing with electrocardiographic monitoring. Porto Biomed J. 2023;8:e235. doi: 10.1097/j.pbj.0000000000000235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- World Medical Association World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194. doi: 10.1001/jama.2013.281053. [DOI] [PubMed] [Google Scholar]
